Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 77
Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces Appendix PRESENTERS AT THE SEPTEMBER 5, 1995, COMMITTEE MEETING Anna Johnson-Winegar, Ph.D. Director Medical Chemical and Biological Defense Directorate U.S. Army Medical Research and Materiel Command LTC Claude Woodard, D.V.M. Medical Chemical and Biological Defense Directorate U.S. Army Medical Research Institute of Infectious Diseases LTC Edward M. Eitzen, M.D., and LTC Phillip Pittman, M.D. U.S. Army Medical Research Institute of Infectious Diseases LTC James King, Ph.D. Chief, Research Operations Division U.S. Army Medical Research Institute of Chemical Defense LTC Robert F. DeFraites, M.D. Walter Reed Army Institute of Research PRESENTERS AT THE MARCH 5–6, 1996, COMMITTEE MEETING COL George Lewis Commander U.S. Army Medical Materiel Development Activity, Fort Detrick Ron Clawson, Ph.D. U.S. Army Medical Materiel Development Activity, Fort Detrick
OCR for page 78
Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces Judy Pace, Ph.D. U.S. Army Medical Materiel Development Activity, Fort Detrick Rick Kenyon, Ph.D. U.S. Army Medical Materiel Development Activity, Fort Detrick MAJ John Grabenstein Clinical Investigation Regulatory Office Army Medical Department Center and School LtCol John T. Graham Defence Medical Services Directorate, British Ministry of Defence United Kingdom COL John Brundage, M.D., MPH Director, Epidemiology and Disease Surveillance USA Center for Health Promotion and Preventive Medicine Susan Ellenberg, Ph.D. Director, Division of Biostatistics and Epidemiology Food and Drug Administration Robert Chen, Ph.D. Chief, Vaccine Safety and Development Centers for Disease Control and Prevention
Representative terms from entire chapter: